Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present ALR Technologies, Inc. (OTC: ALRT).

Full DD Report for ALRT

You must become a subscriber to view this report.


Recent News from (OTC: ALRT)

ALR Technologies and IDEAS DWC LLC to Market the ALRT Diabetes Solution In the Middle East and North Africa
ALRT’s comprehensive diabetes management system could improve outcomes and provide diagnostic tools for diabetes therapies in one of the world’s most critical diabetes markets RICHMOND, Va., Oct. 01, 2018 (GLOBE NEWSWIRE) -- ALR Technologies Inc. (OTCPINK: ALRT) has signe...
Source: GlobeNewswire
Date: October, 01 2018 08:00
ALR Technologies (ALRT) and Aspire Cerebro Agree to Co-Market the ALRT Diabetes Solution In India
ALRT and Aspire Cerebro will coll aborate to market ALRT’s comprehensive diabetes management system to Indian pharmaceutical companies and help improve diabetes management RICHMOND, Va., Aug. 27, 2018 (GLOBE NEWSWIRE) -- ALR Technologies Inc. (OTCPINK: ALRT) has signed a...
Source: GlobeNewswire
Date: August, 27 2018 08:00
ALRT announces launch of the Integrated ALRT Diabetes Solution ("Integrated Solution")
RICHMOND, Va., June 28, 2018 (GLOBE NEWSWIRE) -- ALR Technologies Inc. (OTCPINK:ALRT) will be offering Integrated Solution to health insurance payers to help their clinical teams deliver best practice diabetes care to insulin dependent and non-insulin dependent patients.  Integrated So...
Source: GlobeNewswire
Date: June, 28 2018 15:58
ALR Technologies Announces That Its ALRT Diabetes Solution Has Been Developed to an Enterprise-Scale
The ALRT Diabetes Solution is an enterprise-scale product that allows healthcare systems to implement best practices for diabetes care on large populations of patients - saving lives and money. “REPRESENTS A FUNDAMENTAL SHIFT IN DIABETES CARE” Company assembles...
Source: GlobeNewswire
Date: May, 14 2018 08:08
260 Marijuana Stocks: Equal-Weighted Portfolio Up Nearly 7% For The Week Ending January 19, 2018
I Still Day-Trade and Like the Marijuana Sector, but I Want a Bit of Safety, as Well As we prepare for 3 or 4 Federal Reserve interest rate increases for calendar year 2018, I am easing out of my Fidelity mutual funds. At the age of 60, I find myself focusing on capital preservation, and w...
Source: SeekingAlpha
Date: January, 22 2018 05:36

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-120.04050.0410.0410.0411,250
2018-12-110.040.04180.04180.043,717
2018-12-100.0410.0410.0410.0411,000
2018-12-070.040890.0410.0410.040528,967
2018-12-06N/A0.04325N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-04106,736170,10062.7490Short
2018-12-038,70575,96211.4597Cover
2018-11-2817,00063,55026.7506Cover
2018-11-2710,00053,20018.7970Cover
2018-11-21118,344284,11941.6530Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ALRT.


About ALR Technologies, Inc. (OTC: ALRT)

Logo for ALR Technologies, Inc. (OTC: ALRT)

ALR Technologies is a medical device company providing remote monitoring and care facilitation for patients with diabetes. ALRT has developed the FDA cleared Health e Connect System which uploads the data from blood glucose meters onto a secure website where clinicians and Diabetes Care Facilitators can better monitor and coordinate the care of diabetes patients. ALRT s system goal is to assist patients to adhere to their care plan, improving the quality of diabetes care and making such care more cost effective to providers.

 

Contact Information

 

 

Current Management

  • Sidney Chan / CEO, CFO, Treasurer
    • Mr. Chan has been involved in managing and developing ALR Technologies since August and was instrumental in taking the company public. Prior to ALR, Mr. Chan had an extensive background in structured finance as President and CEO of the Knight s Group of Companies. Prior to the founding of the Knight s Group of Companies Mr. Chan worked for the predecessor companies of RBC Dominion Securities as well as Cominco, the mining subsidiary of Canadian Pacific. Mr. Chan is an engineer who obtained his Bachelor of Engineering degree with the distinction in Mineral Economics from McGill University.
  • Sidney Chan / Chairman
    • Mr. Chan has been involved in managing and developing ALR Technologies since August and was instrumental in taking the company public. Prior to ALR, Mr. Chan had an extensive background in structured finance as President and CEO of the Knight s Group of Companies. Prior to the founding of the Knight s Group of Companies Mr. Chan worked for the predecessor companies of RBC Dominion Securities as well as Cominco, the mining subsidiary of Canadian Pacific. Mr. Chan is an engineer who obtained his Bachelor of Engineering degree with the distinction in Mineral Economics from McGill University.
  • Ronald Cheng /
  • Kenneth Robulak / Director
    • Mr. Robulak has had an extensive career in corporate finance with major Canadian financial institutions, more recently he provides support services for a manufacturing Company with operations in Dallas, Texas and Guadalajara, Mexico. Mr. Robulak joined the board of ALR Technologies Inc. on December , and served as chief financial officer, secretary and treasurer from April , until he resigned on January , to go to work with Morgan Stanley. Mr. Robulak earned a Bachelor of Commerce degree in finance and marketing and is a Fellow of the Institute of Canadian Bankers.
  • Alfonso Salas / Director
    • Dr. Salas graduated with distinction from Universidad Metroplitana of Barranquilla, Colombia in with a Doctor of Medicine degree. He began practicing in Santa Marta, Columbia in rural medical facilities and the opened a private practice in . He then worked as a physician with a number of shipping companies and became Medical Director in the office of the Ministry of Social Security and Labor of Columbia in doing medical assessments for work related accidents. In Dr. Salas was appointed Director of a Medical Service Plan of Columbia and with a support staff of more than thirty people, maintained a caseload, provided assessment procedures and referral services to hospitals, clinics, and specialists and organized and monitored clinical trials and clinical research in the pharmaceutical and medical field. Since Dr. Salas has operated his own business in Vancouver, British Columbia, providing medical based consulting services for corporations and agencies in Columbia with a focus on budgeting, research and medical services.
  • Peter H. Stafford / Director
    • Mr. Stafford is a retired lawyer and business consultant, having practised with Fasken Martineau DuMoulin LLP, a major Canadian based international law firm, and its predecessor firms, from to , except for several years spent as inhouse counsel for clients of the firm. Mr. Stafford s experience is in the areas of corporate and securities law, including mergers and acquisitions. From until his retirement from fulltime practice, Mr. Stafford served as senior partner in the business law department at Faskin Martineu DuMoulin LLP, including leading the start of its Johannesburg office in . Since August , Mr. Stafford has served as director, secretary and audit committee chair of Russell Breweries Inc. Formerly, he was a director and subsequently secretary of WEX Pharmaceuticals Inc. until its amalgamation, a director and board chair of BC Bancorp from until its merger with Canadian Western Bank, a director of China One Corporation until it was acquired and a director of a director of Nissho Iwai Canada Ltd. Originally from South Africa, Mr. Stafford obtained a BA from the University of Cape Town and an LL.B from the University of South Africa. He was admitted as an attorney in South Africa and subsequently was called to the English Bar Inner Temple .

Current Share Structure

  • Market Cap: $9,249,838 - 03/16/2018
  • Authorized: 500,000,000 - 02/10/2015
  • Issue and Outstanding: 242,777,909 - 02/10/2015
  • Float: 154,306,740 - 02/10/2015

 


Recent Filings from (OTC: ALRT)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 17 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 10 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 30 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: March, 28 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: March, 14 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: March, 14 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 26 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 26 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 23 2018

 

 


Daily Technical Chart for (OTC: ALRT)

Daily Technical Chart for (OTC: ALRT)


Stay tuned for daily updates and more on (OTC: ALRT)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: ALRT)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ALRT is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ALRT and does not buy, sell, or trade any shares of ALRT. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/